A STUDY ON ENTEROHAEMORRHAGIC E.COLI O157: H7 ASSOCIATED WITH DIARRHEA AND HEMOLYTIC UREMIC SYNDROME IN CHILDREN

Document Type : Research article

Authors

*Dept. of Pediatrics, Fac. of Med., Assiut Univ.

Abstract

Shiga toxin-producing Escherichia coli (STEC) is considered one of the
most important emergent zoonotic food bome pathogens. A total of two
hundred random samples were collected from children with acute
diarrhea. 53 of them had blood in stools, 47 had blood in stools and
associated with hemolytic uremic syndrome (HUS). The other hundred
had no blood in their stools. Samples were collected from the
gastroenterology unit of Assiut Children University Hospital during the
period from October 2003 to September 2004. The present study was
designed to estimate the incidence of STEC 0157:H7 infection among
diarrheal children with and without blood in stools, moreover percentage
frequency of HUS among patients with positive STEC infection was
evaluated and demographic and clinical characteristics of the STEC
patients were investigated. Furthermore antibiotic resistance patterns of
the recovered strains were studied and plasmid profile of the obtained
isolates were performed to elucidate the relation between the obtained
strains. E.coli 0157:H7 could be detected in 16.98%, 17% and 3% of
bloody diarrhea, bloody diarrhea associated with HUS and non bloody
diarrhea, respectively. Ecological distribution of the examined children
revealed that the rate of infection was higher (11.3%) in rural areas than
in urban areas (5%). E.coli 0157:H7 was recovered in children fed on
bottle milk (2.5%) and animal products (17.27%) while it was not
isolated from children with breast feeding. The majority of cases in the
present study were in the age group of 7-24 months with a rate of
(18.3%), followed by those in age group of <7months with a rate of 5%.
It has been estimated that 60% of the isolated strains were resistant to
ampicillin and 10% of them were resistant to erythromycin as well as
5% of the strains were resistant to gentamycin and tetracycline. It was
revealed that out of the isolated 20 isolates of E.coli 0157:H7, 6 (30%)
harboured some copies of plasmids ranging in size from (1.1 to 45
MDa). The obtained strains harbouring plasmids were grouped into
6 plasmid profiles with different molecular weights and this results
reveal the existence of a variety of clones which may indicate several
sources of contamination.

Keywords


Dept. of Animal Hygiene and Zoonoses

Fac. of Vet. Medicine. Assiut Univ.

 

A STUDY ON ENTEROHAEMORRHAGIC

E.COLI O157: H7 ASSOCIATED WITH DIARRHEA AND HEMOLYTIC UREMIC SYNDROME

IN CHILDREN

(With 6 Tables and one Figure)

 

By

AMAL S. M. SAYED and NAGLA M. ABDEL HAFEZ*

*Dept. of Pediatrics, Fac. of Med., Assiut Univ.

(Received at 24/3/2005)

 

دراسة عن ميکروب الإيشريشيا القولونية المعوية النزفية والمصاحبة لحالات الإسهال ومتلازمة انحلال الدم البولينى فى الأطفال

 

أمل سيد محمد سيد ، نجلاء مصطفى عبد الحا فظ

 

 يعتبر ميکروب  E.coli O157:H7 من أهم الميکروبات التى تنتقل إلى الإنسان عن طريق الغذاء الملوث والتى تشکل خطورة على صحة الإنسان وخصوصا فى الأطفال حيث تعتبر متلازمة انحلال الدم البولينى من المضاعفات الشائعة والخطيرة نتيجة للإصابة بهذا الميکروب. وقد  أجريت هذه الدراسة لتحديد نسبة الإصابة بهذا الميکروب وکذلک نسبة حدوث متلازمة انحلال الدم البولينى لدى مجموعة من الأطفال تعانى من  حالات  الإسهال المدمم والإسهال الغير المدمم. لذلک فقد تم جمع عدد 200 عينة عشوائية من براز الأطفال بواقع 100عينة من حالات الإسهال الغير المدمم ، 53 عينة من الإسهال المدمم  و47 عينة من حالات  الإسهال المدمم المصاحب لمتلازمة انحلال الدم البولينى من وحدة الجهاز الهضمى فى مستشفى الأطفال بأسيوط فى الفترة من اکتوبر 2003 إلى سبتمبر 2004. وقد تم عزل الميکروب  بنسبة 16.98% ، 17%  و3 % لکل من حالات الإسهال المدمم، حالات الإسهال المدمم والمصاحب لمتلازمة انحلال الدم البولينى وحالات  الإسهال الغير المدمم على التوالى. وقد ارتفعت نسبة الإصابة بين الأطفال فى الريف (11.3%) عن المدينة (5%) وتم عزل الميکروب من الأطفال التى تم تغذيتهم على منتجات ذات الأصل الحيوانى بنسبة 17.27% و 2.5 % للألبان الصناعية. وقد اثبتت الدراسة أن غالبية المرضى من الأطفال کانت تتراوح أعمارهم بين( 7-24 شهر) وکانت نسبة الإصابة بينهم (18.3%) بينما کانت نسبة الإصابة (5 %) بين الأطفال التى تتراوح أعمارهم اقل من         7شهور. کما أظهرت النتائج أن الإصابة کانت اعلى بين الذکور(11.4%) عن الإناث        (6.67%). وقد تمت دراسة مدى حساسية العترات المعزولة، وأظهرت النتائج أن 60% من العترات قاومت الکلورامفنيکول وان 30% من العترات کانت مقاومة للأمبسيلين، 10% من العترات قاومت الأيرثروميسن وان 5% من العترات کانت مقاومة لکل من الجينتاميسين والتيتراسيکلين، ودلت النتائج ان 30% من العترات کانت تحمل البلازميد وتراوح وزنه الجزيئى بين 1.1- 45 ميجا دالتون. وقد تمت مناقشة الأهمية الصحية والوبائية لميکروب         E.coli O157:H7 ومصادر التلوث المختلفة، هذا بالإضافة إلى مناقشة التوصيات لکيفية الحد من انتشار هذا الميکروب وکيفية الوقاية منه.

 

Summary

 

Shiga toxin-producing Escherichia coli (STEC) is considered one of the most important emergent zoonotic food borne pathogens. A total of two hundred random samples were collected from children with acute diarrhea. 53 of them had blood in stools, 47 had blood in stools and associated with hemolytic uremic syndrome (HUS). The other hundred had no blood in their stools. Samples were collected from the gastroenterology unit of Assiut Children University Hospital during the period  from October 2003 to September 2004. The present study  was designed to estimate the incidence of STEC O157:H7 infection among diarrheal children with and without blood in stools, moreover percentage frequency of HUS among patients with positive STEC infection was evaluated and demographic and clinical characteristics of the STEC patients were investigated. Furthermore antibiotic resistance patterns of the recovered strains were studied and plasmid profile of the obtained isolates were performed to elucidate the relation between the obtained strains. E.coli O157:H7 could be detected in 16.98%, 17% and 3% of bloody diarrhea, bloody diarrhea associated with HUS and non bloody diarrhea, respectively. Ecological distribution of the examined children revealed that  the rate of infection was higher (11.3%) in rural areas than in urban areas (5%). E.coli O157:H7 was recovered in children fed on bottle milk (2.5%) and animal products (17.27%) while it was not isolated from children with breast feeding. The majority of cases in the present study were in the age group of 7-24 months with a rate of (18.3%), followed by those in age group of <7months with a rate of 5%. It has been estimated that 60% of the isolated strains were resistant to ampicillin and 10% of them were resistant to erythromycin as well as 5% of the strains were resistant to gentamycin and tetracycline. It was revealed that out of the isolated 20 isolates of E.coli O157:H7, 6 (30%) harboured some copies of plasmids ranging in size from (1.1 to 45 MDa). The obtained strains harbouring plasmids were grouped into        6 plasmid profiles with different molecular weights and this results reveal the existence of a variety of clones which may indicate several sources of contamination.

Key words: E.coli O157:H7, Diarrhea, Children, Hemolytic uremic syndrome, Antimicrobial susceptibility, plasmid profile.

 

Introduction

 

Shiga toxin-producing Escherichia coli (STEC), especially of serotype O157:H7 is considered one of the most important emergent zoonotic food borne pathogens constituting a worldwide public health problem either in the form of individual cases of infections or outbreaks (Leclercq et al., 2001). Epidemiological investigators revealed that different species of animals may act as a reservoir of E. coli O157:H7 (Nelson et al., 1998). STEC infection in man have been associated with consumption of food of animal origin especially undercooked beef or raw milk including cow,s,  goat,s and ewe,s milk (Little and De Louvois, 1999; Rubin et al., 1999; Stephan and Kuhn, 1999 & Sayed and Husein 2003). Moreover infection may also be waterborne or acquired via person to person transmission in such communities as nursing homes, day care centers, schools and hospitals (Nelson et al., 1998 & Hashimoto et al., 1999).

Shiga toxin- producing   E. coli is associated with wide spectrum of clinical manifestation including non-specific diarrhea, hemorrhagic colitis and life threatening hemolytic uremic syndrome (HUS) which leads to acute renal failure in children and thrombocytopenic purpura, all of which are related to adherence of the pathogen to intestinal tract lining followed by production of one or more vero toxins which is implicated in vascular endothelial damage observed in hemorrhagic colitis and HUS patients (Gray, 1995; Nelson et al., 1998 & Karpman et al., 2001).

E.coli O157:H7 is the prototypic enterohaemorrhagic E.coli (EHEC) which produces potent cytotoxins known as shiga like toxins (SLT) or shiga toxins (STx). Shiga toxins are translocated from the bowel to the circulatory system and transported by leukocytes to capillary endothelial cells in renal glomeruli and other organs (Karmali, 2004). STx have been specifically implicated as a causal factor for HUS because cases with HUS were found to be associated with STx-producing strains;  the toxin has been identified in the kidney of patients with the syndrome; and the toxin was found to be cytotoxic for renal endothelial and epithelial cells (Karpman et al., 2001). The exact mechanism responsible for the syndrome, however, remains speculative. Endothelial injury is considered the primary pathogenic event in diarrhea associated HUS. Moreover, an acute inflammatory response in STEC infection including leukocytes and inflammatory mediators was also suggested to play an important role in the pathogenesis of STEC induced hemolytic uremic syndrome (HUS) by enhancing the effect of shiga toxins produced by the organisms (Litalien et al., 1999).

The present study  was designed to estimate the incidence of STEC O157:H7 infection among diarrheal children with and without blood in stools, moreover percentage frequency of hemolytic uremic syndrome (HUS) among patients with positive STEC infection was evaluated and demographic and clinical characteristics of the STEC patients were investigated. Furthermore antibiotic resistance patterns of the recovered strains were studied and plasmid profile of the obtained isolates were performed to elucidate the relation between the obtained strains.

 

MATERIALS and METHODS

 

Collection of Samples:

Two hundred random stool samples were collected from children with acute diarrhea (53 of them had blood in stools, 47 had blood in stools and associated with HUS while  the other hundred had no blood in stools). Samples were collected from the gastroenterology unit of Assiut Children University Hospital during the period  from October 2003 to September 2004.

Complete case history was reported for each patient including feeding pattern, duration, frequency, consistency and the presence of visible blood in stools, presence of fever, convulsions or other neurological insults, and history of antibiotic administration before or during hospital stay. Diagnosis of the HUS was made according to Chandler et al.,  (2002), using the following criteria:

Platelet count < 150,000/mm³, micro-angiopathic hemolytic anemia (hematocrit below 30% with evidence of reticulocytosis and fragmented erythrocytes on blood peripheral smear) and renal insufficiency as indicated by oliguria or anuria and azotemia. In all children with proven STEC O157:H7 infection, daily complete blood counts were obtained and renal function tests were performed for clinical purposes until the hemolytic uremic syndrome developed and resolved or until it became apparent that the infection was resolving without the occurrence of this complication.

Exclusion criteria:

Cases with diarrhea for more than 2 weeks, those with malnutrition, rickets, or suspected immune deficiency syndromes and those with proven protozoal infection, hemorrhagic disorders or known chronic renal diseases were also excluded from the study.

 

Isolation and identification of E.coli O157:H7:

Enrichment Technique:

Stool samples were enriched in modified Tryptic Soya Broth (mTSB) supplemented with novobiocin (20 mg/liter). The inoculated broth was incubated at 37ºC for 24 hours. (De Boor and Heuvelink,  2000).

Isolation on Sorbitol MacConkey agar:

Loopful from the incubated broth was streaked onto Sorbitol MacConkey agar plates and incubated at 37ºC for 24 hours (De Boor and Heuvelink,  2000).

Identification of E.coli O157:H7:

Non sorbitol fermenter colonies were identified morphologically by Gram’s stain and biochemically as E.coli according to Varnam and Evans, (1991) by the conventional IMViC (indole, methyl red, Voges Proskauer and Citrate utilization) and Triple sugar iron agar. A latex agglutination test (E.coli O157, Oxoid diagnostic reagents 620 M) was used for identification of E.coli serogroup O157 isolates. The Oxoid     E. coli O157 latex was demonstrated by slide agglutination of E.coli strains possessing the O157 serogroup antigen according to Vernozy-Rozand, (1997). Bacto E.coli H7 antisera (Difco) was used to identify H7 strains according to manfacture's procedure.

Antibiotic susceptibility test:

The antibiotic sensitivity patterns were determined for the recovered strains by using the disc diffusion  method (Schroeder et al., 2002). The following antibiotic discs were used: ampicillin 10µg, chloramphenicol (30µg), erythromycin (15µg), gentamycin (10µg) and tetracycline (30µg).

Extraction of plasmid DNA:

E.coli O157:H7 strainswere purified on Sorbitol MacConkey agar plates and incubated at 37 ºC for 24 hours (De Boor and Heuvelink, 2000). Single colony was picked and inoculated in 10ml of Luria Bertani broth (LB) and grown in microaerophilic condition at 37ºC for 10h. Plasmid extraction were done by using the alkaline lysis procedure as described by Woodford et al., (1994).

Agarose gel electrophoresis:

10µl of the extracted plasmid was mixed with 10µl of loading buffer and the aliquots were loaded onto 0.7% agarose gel stained with ethidium bromide (0.5µg/ml). Electrophoresis was carried out at 90 v for 2-3h and visualized under UV transillumination (Biometra) at 320 nm and photographed (Woodford et al., 1994). E.coli (V517) containing plasmids of molecular weight ranged from 1.4-35.8 MDa was used as molecular weight standard marker. The molecular weight of plasmids were calculated by blotting electrophortic mobility of plasmid and the standard molecular weight marker.

 

Results

 

Table 1:Incidence of Escherichia coli O157:H7 among the examined  children

 

Type of Diarrhea

Examined samples

No.of infected

children

%

Bloody

53

9

16.98

Bloody+HUS*

47

8

17

Non bloody

100

3

3

Total

200

20

10

 

*HUS: Haemolytic uremic syndrome.

 

Table 2: Ecological distribution of STEC infection among the examined children

 

   Residence

Examined

samples

 

No. of infected

children

 

%

Rural

 

160

18

11.3

Urban

 

40

2

5

 

STEC: Shiga toxin producing Escherichia coli

 

Table 3: Feeding pattern of the examined children

 

Type of Feeding

No. of samples

No. of infected children

%

Breast

50

-

-

Bottle

40

1

2.5

Animal products*

110

19

17.27

* Children fed on breast milk or bottle milk together with animal products.

 

Table 4: Age-wise incidence of STEC infection among the examined children

 

  Age-wise

months

Type of Diarrhea

Bloody

Bloody + HUS

Non-bloody

Total

 

No. of samples

No. of infected children

%

No. of samples

No. of infected children

%

No. of samples

No. of infected children

%

No.

 

%

<7

12

2

16.7

17

1

5.9

31

-

-

3

5

7- 24

26

7

26.9

19

7

36.9

48

3

6.3

17

18.3

> 24

15

-

-

11

-

-

21

-

-

-

-

 

STEC: Shiga toxin producing Escherichia coli

 

Table 5: Occurrence of STEC infection in male and female patients

 

Sex

Examined samples

No. of infected children

 

%

Male

 

140

16

11.4

Female

 

60

4

6.67

 

   STEC: Shiga toxin producing Escherichia coli

 

Table 6: Antibiotic sensitivity pattern of the isolated STEC strains

 

Antimicrobial agents

Sensitive

Resistant

 

No./20

No./20

Ampicillin

14                     70%

 6                  30%

Chloramphenicol

 8                       40%

12                60%

Erythromycin

18                     90%

 2                  10%

Gentamycin

19                     95%

 1                  5%

Tetracycline

19                     95%

 1                  5%

 

STEC: Shiga toxin producing Escherichia coli

 

       Figure 1: Plasmid profile of E.coli O157:H7 isolates.

M: E.coli V517 marker. Plasmid bearing isolates:2,4,5,6,7,8

Lane 2:   ( 31, 12 , 1.9 , 1.6, 1.1 MDa) ;  lane 4: (25, 10.5 MDa);

lane 5: (1.5 MDa); lane 6: (7 MDa); lane 7: (2.7 , 1.2 MDa);

lane 8: (45 MDa).

 

Discussion

 

Episodes of diarrhea continues to be a major cause of childhood mortality among children in developing countries (Kosek et al., 2003). Most episodes of bloody diarrhea among children in developing countries result from intestinal infection and nearly all of these are caused by invasive bacteria (WHO, 1994). Compared to the most other foodborne illness, infections involving STEC O157:H7 or other EHEC strains are particularly serious with life threatining post-diarrheal disorder. The infection caused by this organism have probably increased in incidence during the past several decades (Tarr, 1994).

            The present study emphasizes the importance of STEC O157:H7 in children with diarrhea.It has been estimated that the incidence of STEC O157:H7 was 10% among the examined children (Table 1). It was isolated from 3%, 16.98% and 17% of the examined children with nonbloody diarrhea, bloody diarrhea and bloody diarrhea acompanied with HUS, respectively as illustrated in (Table 1). It has been estimated that the attack rate of STEC infection among children ranged from 0.1% to 71% (Griffen and Tauxe, 1991). In addition Pai et al., (1988);  Ramotor et al., (1995) and Buteau et al., (2000) & Loirat, (2001) isolated STEC from children with diarrhea with a rate of 3.2 %, 0.6 %, 12% and 85%, respectively. The differences in the reported prevalence rates could be attributed to difference in the contamination rates in the studied areas.

Haemolytic uremic syndrome is defined by triad of features: acute renal failure, thrombocytopenia and microangiopathic haemolytic anaemia. Although there are different varieties of HUS, the most common form, by far is classical ; or D+(diarrhea associated) which is a leading cause of acute renal failure in childhood (Nelson et al., 1998). The presence of blood in diarrheal stools in children is presumed to be a sign of invasive enteric infection that carries a risk of serious morbidity and mortality (WHO, 1994). Stools from patients with STEC infection are sometimes  described as "all blood and no stool" thus simulating gastrointestinal hemorrhage (Tayler and Monnens, 1998). Results of the present study revealed that among patients with STEC infection who had bloody diarrhea, (17%) developed the HUS within a week of the first symptoms, while none of the nine cases of bloody diarrhea developed the syndrome (Table 1). The incidence of HUS among STEC infected children was variably reported by several authors including (Boyce et al., 1995) who reported HUS in 6% of infected cases usually within 2-12 days of the onset of diarrhea. However, both Wong et al., (2000)  and Chandler et al., (2002) indicated that HUS developed soon after the onset of diarrhea in 15% of children infected with STEC.

Previous epidemiological investigations contributed that contact with farm animals especially with cattle as well as contamination of food and water were considered the most important risk factors for acquiring STEC infection (Michel et al., 1999). Ecological distribution of the infected children in the present study (Table 2) revealed that the incidence of infection was higher in rural areas (11.3%) than in urban areas (5%). These results reflect  the high contamination rates with STEC  in rural areas. Our results are in agreement with that reported by Poitrineau et al., (1995). Furthermore feeding pattern of the examined children illustrated in (Table 3) indicates that infection was high (17.27%) among children fed on breast or bottle milk together with animal products than those who fed on bottle milk only (2.5%). In addition non of the children fed on breast milk were infected. The obtained results indicates the role of animal products as a source of infection.

It has been estimated that the peak age-related frequency of STEC associated diarrhea and HUS was reported in young children (Nelson et al., 1998). The highest incidence of STEC infection was recorded in children less than 5 years, and the HUS has been reported to be a more likely complication in younger children (Salmon et al., 1999). The increased rate of STEC infection and HUS in children less than        5 years old suggests that immunity could play some role, moreover, younger age children may be highly susceptible to greater toxicity of STEC (Nelson et al., 1998). However, protective immunity has not been demonstrated and even children without immunologic abnormalities have been infected more than once (Elliott et al., 2001). The  majority of cases in the present study (Table 4) were in the age group of  7-24 months (18.3%) with a rate of 26.9% , 36.9% and 6.3% for children with bloody diarrhea, bloody diarrhea associated with HUS and non bloody diarrhea, respectively. However the incidence of STEC O157:H7 in the  age group of <7 months was (5%) as illustrated in (Table 4) with a rate of 16.7% and 5.9% for children with bloody diarrhea, bloody diarrhea associated with HUS, respectively. Our results are in parrallel with that reported by  Poitrineau  et al., (1995) & Tozzi et al., (2003). In addition results in (Table 5) declared  that STEC O157:H7 was isolated from 11.4% and 6.67% of the examined males and females, respectively. Simillar findings were reported by Poitrineau et al., (1995).

Antimicrobials are routinely used for disease prevention and growth promotion in animal production. This practice leads to the emergence and dissemination of antimicrobial resistance in STEC which poses a public health threat. (Witte, 1998 &  Schroeder et al., 2002). The obtained results in (Table 6) declared that 60% of the obtained strains were resistant to chloramphenicol followed by 30% of the strains were resistant to ampicillin and 10% of them  were resistant to erythromycin as well as 5% of the strains were resistant to gentamycin and tetracycline. Simillar findings were reported by several authors       (Meng et al., 1998; Aarestrup and Wegener, 1999; Galland et al., 2001 & Zhao et al., 2001). These results indicate the presence of multiple antibiotic resistant strains of  E. coli O157: H7 which  is considered a public health hazard.

Plasmid profile is considered as a useful strain molecular marker that distinguish the epidemic clone of a particular pathogen and help to identify specific vehicles of infection. (Wachsmuth et al., 1991 &Taguchi et al., 2000). It was investigated that out of  the isolated 20 isolates of E.coli O157:H7, 6 (30%) harboured some copies of plasmids ranging in size from (1.1 to 45 MDa) as illustrated in (Figure 1). The obtained strains harbouring plasmids were grouped into 6 plasmid profiles with different molecular weights (lane 2: 31, 12, 1.9, 1.6, 1.1 MDa);  lane 4: (25, 10.5 MDa); lane 5: (1.5 MDa); lane 6: (7 MDa);  lane 7: (2.7, 1.2 MDa); lane 8: (45 MDa) and this results indicate the existence of a variety of clones which may point to the presence of several sources of contamination and the recovered isolates were epidemiologically different.

Conclusion and recommendation:

Shiga toxin producing Escherichia coli (STEC) infection was found to be relatively high among hospitalized children pointing to the role of  food of animal origin especially milk and milk products which is considered as the most important source of transmission of STEC. The basic elements of food hygiene in the home and institutional setting need to be advocated aggressively in public education campaigns, especially through the popular media. The data presented by this study reinforce the importance of keeping STEC out of food chain at the farm level, preventing its dissemination in the food manufacturing process and cooking food of animal origin adequately to prevent infection at point of consumption. Moreover, infection with this organism may cause severe disease and complications including HUS with fatal outcome, so it is recommended that stool specimens from all patients with a history of acute bloody diarrhea should be cultured for STEC O157:H7. Early detection of cases with STEC infection can prevent additional cases particularly in hospitalized children and those attending day care centers. Separation of the infected children until two consecutive stool cultures are negative for STEC can prevent further transmission. It is highly recommended that during the week after the onset of acute bloody diarrhea, patients with documented STEC infection should be monitored for signs and symptoms of the HUS such as pallor, oliguria, peripheral blood smears, blood counts and urine analysis during this period. However, the most important prevention measure is supervised by hand washing and health education of mothers and caregivers of infected children.The policy of using empirical antibiotics for treatment of diarrheal cases with blood in stools before results of stool culture and sensitivity testing should be revised. It is recommended not to give antibiotics to children who are infected with STEC unless it is approved by stool culture and sensitivity testing for the appropriate antibiotic treatment.

 

References

 

Aarestrup, F.M. and Wegener, H.C. (1999): The effect of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microbes Infect. 1: 639 - 644.

Boyce, T.G.; Swerdlow, D.L. and Griffen, P. (1995): Escherichia coli O157:H7 and the hemolytic uremic syndrome. N. Eng. J. Med. 10: 364-368.

Buteau, C.; Proulx, F.; Chaibou, M.; Raymond, A.; Clermont, M.J.; Mariscalco, M.M. and Seidman, E. (2000): Leukocytosis in children with Escherichia coli O157: H7 enteritis developing the hemolytic –uremic syndrome. Pediatr. Infect. Dis. J. 19 (7): 642-647.

Chandler, W.L.; Jelacic, S.; Boster, D.R. ; Ciol, M.A. and Williams, G.D. (2002):  Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N. Eng. J. Med. 346:23 -32.

De Boor, E. and Heuvelink, A.E. (2000):Methods for the detection and isolation of shiga-toxin producing  E.coli.  J. Appl. Microbiol. Symposium supplement 88: 133-143.

Elliott, E.J.; Robins-Browne, R.M.; O'Loughlin, E.V. and Bennett-Wood, V. (2001): Nationwide study of hemolytic uremic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child  85: 125-131.

Galland, J.C.; Hyatt, C.R.; Crupper, S.S.  and Acheson, D.W. (2001): Prevalence, antibiotic suceptibilty, and diversity of Escherichia coli O157: H7 isolates from a longitudinal study of beef cattle. Appl. Environ. Microbiol. 67:1619-1627.

Gray, L.D. (1995): Escherichia, Salmonella, Shigella and Yersinia, In: Murray, P.R.; Baron, E.J.; Pfaller, M.A.; Tenover, F.C. and Yolken, R.H. Manual of clinical Microbiology 6th ed. Wasshington, D.C. ASM Press p450.

Griffen, P.W. and Tauxe, R.V. (1991): The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E.coli & the associated hemolytic uremic syndrome. Epidemiol. Reviews 13: 60-98.

Hashimoto, H.; Mizukoshi, K.; Nishi, M. and Kawakita, T. (1999): Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to shiga toxin1 - producing Escherichia coli 0118: H2 at a Junior high school in Japan.  Pediatrics 103: 1-5. 

Karmali, M.A. (2004): Infection by shiga toxin-producing Escherichia coli: an overview. Mol. Biotechnol. 26 (2):117-122.

Karpman, D.; Papadopoulou, D. and Nilsson, K. (2001): Platelete activation  by shiga toxin and circulatory factors as a pathogenic mechanism in the  hemolytic uremic syndrome. Blood 97: 3100-3108.

Kosek, M .; Bern, C. and Guerrent, C. (2003): The global burden of diarrheal diseases, as estimated from studies published between 1992 and 2000.  Bull. WHO. 81:197-204.

Leclercq, A.; Lambert, B.; Pierard, D. and Mahillon, J. (2001): Particular biochemical profiles forenterohemorrhagic Escherichia coli O157:H7 isolates on the ID 32 E system. J. Clinic. Microbiol. 39 (3): 1161-1164.

Litalien, C.;  Proulx, F.; Mariscalco, M.M. and Robitaille, P. (1999): Circulating inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr. Nephrol. 13: 840-845.

Little, C.L. and De Louvois, J. (1999): Health risks associated with unpasteurized goat ,s and ewe, s milk on retail sale in England and Wales. APHLS Dairy products Working Group study. Epidemiol. Infect.122 (3) 403-408.

Loirat, C. (2001): Post-diarrheal hemolytic uremic syndrome: clinical aspects. Arch.Pediat. 4 :776-784.

Meng, J.;  Zhao, S.; Doyle, M.P. and Joesph, S.W. (1998): Antibiotic resistance of Escherichia coli O157:H7 and O157; NM from animals, food and humans. J. Food  Prot. 61:1511-1514.

Michel, P.; Wilson, J.B.; Martin, R.C.; Clarke, S.A.; McEven, S.A. and Gyles, C.L. (1999): Temporal and geographical distribution of reported cases of Escherichia coli O157:H7 infection in Ontario. Epidemiol. Infect.122: 193-200

Nelson, S.; Clarke, R.C. and Karmali, M.A. (1998): Verocytotoxin-producing Escherichia coli (VTEC) infection. In Palmer, S.R.; Lord Soulsby and Simpson, DIH. Zoonoses. Biology, Clinical practice and public health control.Oxford University press. pp 89-104.

Pai, C.H.; Ahmed, N.; Lior, H.; Johhnson, W.M.;  Sims, H.V. and Woods, D.E. (1988): Epidemiology of sporadic diarrhea due to verotoxin- producing Escherichia coli : a two year  prospective study.  J. Infect. Dis. 157:1054-1057.

Poitrineau, P.; Forestier, C.;  Myer, M.; Jallat, C.; Rich, C.; Malpuech, G. and De Champs, C. (1995): Retrospective case-control study of diffusely adhering Escherichia coli and clinical features in children with diarrhea. J  Clinic. Microbiol. 33 (7): 1961-1962.

Ramotar, K.; Henderson, E.;  Szumski, R. and Louie,T.J. (1995): Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli. J. Clinic. Microbiol.       33 (5): 1114-1120.

Rubin, S.; Cardeti, G.; Amiti, S.; Manna, G.; Onorati, R.;  Capriali, A. and Morabito, S. (1999): Verocytotoxin-producing Escherichia coli O157 in sheep milk. Vet.Rec. 9 (144) 2: 56

Salmon, R.L.;  Walker, A.M.;  Williams, H.M. and Cheasty, T. (1999): Outbreak of Escherichia coli in a nursey: lessons for prevention. Arch. Dis. Child 81: 60-63.

Sayed, Amal, S.M. and Husein, Asmaa, A.A. (2003): Occurrence of E.coli O157:H7 in apparently healthy dairy cattle and retail milk. Assiut Vet. Med. J. 49 (97) : 211-221.

Schroeder, C.M.; Zhao, C.; Debroy, C.; Torcolini, J.; Zhao, S.; Walker, R.D. and Meng, J. (2002): Antimicrobial resistance of Escherichia coli O157 isolated from Humans, Cattle, Swine and Food.  Appl. Environ. Microbiol. 68 (2): 576-581.

Stephan, R. and Kuhn, K. (1999): Prevalence of verotoxin-producing Escherichia coli mastitis and their antibiotic resistance patterns. 46(6) : 423-427.

Taguchi, M.; Seto, K. and Kobayashi, K. (2000): Epidemiological analysis of shiga toxin producing Escherichia coli O157 isolates from familial infection. Kansenshogaku Zasshi. 74(2): 104-111.

Tarr, P.I. (1994): Escherichia coli O157:H7: overview of clinical and epidemiological issues. J. Food Prot. 57 (70) :632-636.

Tayler, C.M. and Monnens, L.A.H. (1998): Advances in hemolytic uremic syndrome. Arch. Dis. Child 78: 190-193.

 

Tozzi, A.E.; Caprioli, A.;  Minelli, F.;  Gianviti, A. and De Petris, L. (2003): Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. CDC, 9 : 1-5.

Varnam, A.H. and Evans, M.G. (1991): Foodborne pathogens. An illustrated Textbook. Wolfe Publishing Ltd., New York pp. 209-234.

Vernozy-Rozand, C. (1997): A review: Detection of E. coli O157:H7 and other verotoxin producing E. coli (VTEC) in food. J. Appl. Bacteriol. 82: 537-551.

Wachsmuth, I.K.; Kiehlbauuch, J.A.; Bopp, C.A.; Cameron, D.N.; Strockbine, N.A.; Wells, J.G.  and Blake, P.A. (1991): The use of plasmid profile and nucleic acid probes in epidemiologic investigations of foodborne, diarrheal diseases. Int. J. Foodborne Microbiol. 12 (1): 77-89

WHO, Programme for control of diarrheal diseases (1994): The management of bloody diarrhea in young children. World Health Organization Geneva. Document.WHO/CDD/94.49.

Witte, W. (1998): Medical consequences of antibiotic use in agriculture. Science 279: 996-997.

Wong, C.S.;  Jelacic, S.;  Habeeb, R.L. and Watkins, S.L. (2000): The risk of the hemolytic uremic  syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Eng J. Med. 342: 1930-1936.

Woodford, N.; Johnson, A.P. and Threfall,  E.J. (1994): Extraction and fingerprinting of bacterial plasmids. In: Methods in Practical Laboratory Bacteriology. Chart, H. (ed) CRC., Boca Raton, pp.93-105.

Zhao, T.;  Doyle, M.P.;  Shere, J. and Garber, I. (2001): Identification and characterization of integron-mediated antibiotic resistance among shiga toxin-producing Escherichia coli isolates. Appl. Environ. Microbiol. 67:1558-1564.

 

 

 

 

REFERENCES
Aarestrup, F.M. and Wegener, H.C. (1999): The effect of antibiotic
usage in food animals on the development of antimicrobial
resistance of importance for humans in Campylobacter and
Escherichia coli. Microbes Infect. 1: 639 - 644.
Boyce, T.G.; Swerdlow, D.L. and Griffen, P. (1995): Escherichia coli
O157:H7 and the hemolytic uremic syndrome. N. Eng. J. Med.
10: 364-368.
Buteau, C.; Proulx, F.; Chaibou, M.; Raymond, A.; Clermont, MJ;
Mariscalco, MM. and Seidman, E. (2000): Leukocytosis in
children with Escherichia coli 0157: H7 enteritis developing the
hemolytic —uremic syndrome. Pediatr. Infect. Dis. J. 19 (7): 642-
647.
Chandler, W.L.; Jelacic, S.; Boster, D.R. ; Ciol, M.A. and Williams,
G.D. (2002): Prothrombotic coagulation abnormalities preceding
the hemolytic-uremic syndrome. N. Eng. J. Med. 346:23 -32.
De Boor, E. and Heuvelink, A.E. (2000): Methods for the detection and
isolation of shiga-toxin producing E.coli. J. Appl. Microbiol.
, Symposium supplement 88: 133-143.
Elliott, E.J.; Robins-Browne, R.M; O'Loughlin, E.V. and Bennett-Wood,
V. (2001): Nationwide study of hemolytic uremic syndrome:
clinical, microbiological, and epidemiological features. Arch Dis
Child 85: 125-131.
Galland, J.C.; Hyatt, C.R.; Crupper, SS. and Acheson, D.W. (2001):
Prevalence, antibiotic suceptibilty, and diversity of Escherichia
coli 0157: H7 isolates from a longitudinal study of beef cattle.
Appl. Environ. Microbiol. 67:1619-1627.
Gray, L.D. (1995): Escherichia, Salmonella, Shigella and Yersinia, In:
Murray, P.R.; Baron, E.J.; Pfaller, M.A.; Tenover, F.C. and
Yolken, R.H. Manual of clinical Microbiology 6" ed.
Wasshington, D.C. ASM Press p450.
12
Assiut Vet. Med_ J. Vol. 51 No. 105 April 2005
Griffen, P.W. and Tauxe, R.V. (1991): The epidemiology of infections
caused by Escherichia coli 0157:H7, other enterohemorrhagic
E.coli & the associated hemolytic uremic syndrome. Epidemiol.
Reviews 13: 60-98.
Hashimoto, H.; Mizukoshi, K.; Nishi, M. and Kawakita, T. (1999):
Epidemic of gastrointestinal tract infection including
hemorrhagic colitis attributable to shiga toxinl - producing
Escherichia coli 0118: H2 at a Junior high school in Japan.
Pediatrics 103: 1-5.
Karmali, M.A. (2004): Infection by shiga toxin-producing Escherichia
coli: an overview. Mol. Biotechnol. 26 (2):117-122.
Karpman, D.; Papadopoulou, D. and Nilsson, K. (2001): Platelete
activation by shiga toxin and circulatory factors as a pathogenic
mechanism in the hemolytic uremic syndrome. Blood 97: 3100-
3108.
Kosek, M .; Bern, C. and Guerrent, C. (2003): The global burden of
diarrheal diseases, as estimated from studies published between
1992 and 2000. Bull. WHO. 81:197-204.
Leclercq, A.; Lambert, B.; Pierard, D. and Mahillon, J. (2001):
Particular biochemical profiles for | enterohemorrhagic
Escherichia coli 0157:H7 isolates on the ID 32 E system. J.
Clinic. Microbiol. 39 (3): 1161-1164.
Litalien, C.; Proulx, F.; Mariscalco, MM. and Robitaille, P. (1999):
Circulating inflammatory cytokine levels in hemolytic uremic
syndrome. Pediatr. Nephrol. 13: 840-845.
Little, C.L. and De Louvois, J. (1999): Health risks associated with
unpasteurized goat’s and ewe’s milk on retail sale in England and
Wales. APHLS Dairy products Working Group _ study.
Epidemiol. Infect.122 (3) 403-408.
Loirat, C. (2001): Post-diarrheal hemolytic uremic syndrome: clinical
aspects. Arch.Pediat. 4 :776-784.
Meng, J; Zhao, S.; Doyle, MP. and Joesph, S.W. (1998): Antibiotic
resistance of Escherichia coli O157:H7 and 0157; NM from
animals, food and humans. J. Food Prot. 61:1511-1514.
Michel, P.; Wilson, J.B.; Martin, R.C.; Clarke, S.A.; McEven, S.A. and
Gyles, C.L. (1999): Temporal and geographical distribution of
reported cases of Escherichia coli 0157:H7 infection in Ontario.
Epidemiol. Infect.122: 193-200
Nelson, S.; Clarke, R.C. and Karmali, M.A. (1998): Verocytotoxin-
producing Escherichia coli (VTEC) infection. In Palmer, §.R.;
13
 

Assiut Ver. Med. J. Vol. 51 No. 105 April 2005
Lord Soulsby and Simpson, DIH. Zoonoses. Biology, Clinical
practice and public health control.Oxford University press. pp
89-104.
Pai, C.H.; Ahmed, N.; Lior, H.; Johhnson, W.M; Sims, HV. and
Woods, D.E. (1988): Epidemiology of sporadic diarrhea due to
verotoxin- producing Escherichia coli : a two year prospective
study. J. Infect. Dis. 157:1054-1057.
Poitrineau, P.; Forestier, C.; Myer, M.; Jallat, C.; Rich, C.; Malpuech,
G. and De Champs, C. (1995): Retrospective case-control study
of diffusely adhering Escherichia coli and clinical features in
children with diarrhea. J Clinic. Microbiol. 33 (7): 1961-1962.
Ramotar, K.; Henderson, E.; Szumski, R. and Louie,T.J. (1995): Impact
of free verotoxin testing on epidemiology of diarrhea caused by
verotoxin-producing Escherichia coli. J. Clinic. Microbiol.
33 (5): 1114-1120.
Rubin, S.; Cardeti, G.; Amiti, S.; Manna, G.; Onorati, R.; Capriali, A.
and Morabito, S. (1999): Verocytotoxin-producing Escherichia
coli 0157 in sheep milk. Vet.Rec. 9 (144) 2: 56
Salmon, R.L.; Walker, A.M.; Williams, H.M. and Cheasty, T. (1999):
Outbreak of Escherichia coli in a nursey: lessons for prevention.
Arch. Dis. Child 81: 60-63.
Sayed, Amal, S.M. and Husein, Asmaa, A.A. (2003): Occurrence of
E.coli 0157:H7 in apparently healthy dairy cattle and retail milk.
Assiut Vet. Med. J. 49 (97) : 211-221.
Schroeder, C.M.; Zhao, C.; Debroy, C.; Torcolini, J.; Zhao, S.; Walker,
RD. and Meng, J. (2002): Antimicrobial resistance of
Escherichia coli 0157 isolated from Humans, Cattle, Swine and
Food. Appl. Environ. Microbiol. 68 (2): 576-581.
Stephan, R. and Kuhn, K. (1999): Prevalence of verotoxin-producing
Escherichia coli mastitis and their antibiotic resistance patterns.
46(6) : 423-427.
Taguchi, M.; Seto, K. and Kobayashi, K. (2000): Epidemiological
analysis of shiga toxin producing Escherichia coli 0157 isolates
from familial infection. Kansenshogaku Zasshi. 74(2): 104-111.
Tarr, PI. (1994): Escherichia coli 0157:H7: overview of clinical and
epidemiological issues. J. Food Prot. 57 (70) :632-636.
Tayler, C.M. and Monnens, L.A.H. (1998): Advances in hemolytic
uremic syndrome. Arch. Dis. Child 78: 190-193.
14
Assiut Vet. Med. J. Vol. 51 No. 105 April 2005
Tozzi, A.E.; Caprioli, A.; | Minelli, F.;| Gianviti, A. and De Petris, L.
(2003): Shiga toxin-producing Escherichia coli infections
associated with hemolytic uremic syndrome, Italy, 1988-2000.
CDC, 9: 1-5,
Varnam, A.H. and Evans, MG. (1991): Foodborne pathogens. An
illustrated Textbook. Wolfe Publishing Ltd., New York pp. 209-
234.
Vernozy-Rozand, C. (1997): A review: Detection of E. coli 0157:H7 and
other verotoxin producing FE. coli (VTEC) in food. J. Appl.
Bacteriol. 82: 537-551.
Wachsmuth, 1.K.; Kiehlbauuch, J.A.; Bopp, C.A.; Cameron, D.N.;
Strockbine, N.A.; Wells, J.G. and Blake, P.A. (1991): The use of
plasmid profile and nucleic acid probes in epidemiologic
investigations of foodborne, diarrheal diseases. Int. J. Foodborne
Microbiol. 12 (1): 77-89
WHO, Programme for control of diarrheal diseases (1994): The
management of bloody diarrhea in young children. World Health
Organization Geneva. Document. WHO/CDD/94.49.
Witte, W. (1998): Medical consequences of antibiotic use in agriculture.
Science 279: 996-997.
Wong, C.S.; Jelacic, S.; Habeeb, R.L. and Watkins, S.L. (2000): The
risk of the hemolytic uremic syndrome after antibiotic treatment
of Escherichia coli 0157:H7 infections. N. Eng J. Med. 342:
1930-1936.
Woodford, N.; Johnson, A.P. and Threfall, E.J. (1994): Extraction and
fingerprinting of bacterial plasmids. In: Methods in Practical
Laboratory Bacteriology. Chart. H. (ed) CRC., Boca Raton,
pp.93-105.
Zhao, T.; Doyle, M.P.; Shere, J. and Garber, I. (2001): Identification
and characterization of integron-mediated antibiotic resistance
among shiga toxin-producing Escherichia coli isolates. Appl.
Environ. Microbiol. 67:1558-1564.